Post-covid-19
9
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
11.1%
1 terminated out of 9 trials
87.5%
+1.0% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
Cognitive Training and Brain Stimulation in Patients With Post-COVID-19 Cognitive Impairment
Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment
To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19
Effects of Post-COVID-19 on Quadriceps Femoral Muscle-tendon Unit
Changes in Selected Function- and Participation-related Characteristics in Post-COVID Patients Following Pneumological Phase II Rehabilitation
Sleep Characteristics in Post-COVID-19 Patients
At Home REhabilitation and Monitoring of People in poST-covid Condition Through ARc-inTellicare Platform (RESTART/RICOMINCIARE)
The Effects of Video-based Yoga Interventions for Patients With Post-corona Virus Disease
Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection